AN2 Therapeutics (ANTX) Receivables - Other (2022 - 2026)
AN2 Therapeutics' (ANTX) quarterly Receivables - Other came in at $300000.0 in Q1 2026, little changed year-on-year from $300000.0 in Q1 2025, and down 25.0% on a QoQ basis from $400000.0 in Q4 2025.
AN2 Therapeutics (ANTX) Receivables - Other (2022 - 2026) Analysis & Trends
AN2 Therapeutics (ANTX) has 5 years of Receivables - Other data on file, last reported at $300000.0 in Q1 2026.
- On a quarterly basis, Receivables - Other changed 0.0% year-over-year to $300000.0 in Q1 2026; TTM through Mar 2026 was $300000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $400000.0, up 33.33% from the prior year.
- Receivables - Other for Q1 2026 stood at $300000.0, down from $400000.0 in the prior quarter.
- Over the last five years, Receivables - Other for ANTX reached as high as $500000.0 in Q3 2023 and fell as low as $200000.0 in Q4 2022.
- Historically, Receivables - Other has averaged $328571.4 across 5 years, with a median of $300000.0 in 2024.
- Across the five-year window, Receivables - Other surged 100.0% in 2023 and sank 40.0% in 2024, its largest moves.
- Year by year, Receivables - Other stood at $200000.0 in 2022, then jumped by 100.0% to $400000.0 in 2023, then slipped by 25.0% to $300000.0 in 2024, then soared by 33.33% to $400000.0 in 2025, then slipped by 25.0% to $300000.0 in 2026.
- Per Business Quant data, the three most recent Receivables - Other figures were $300000.0 in Q1 2026, $400000.0 in Q4 2025, and $400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AN2 Therapeutics | 167.57 Mn | 167.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |